These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18293994)

  • 21. Ring-Closing Metathesis on Commercial Scale: Synthesis of HCV Protease Inhibitor Simeprevir.
    Horváth A; Depré D; A Vermeulen WA; Wuyts SL; Harutyunyan SR; Binot G; Cuypers J; Couck W; Den Heuvel DV
    J Org Chem; 2019 Apr; 84(8):4932-4939. PubMed ID: 30721066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease.
    Liverton NJ; Holloway MK; McCauley JA; Rudd MT; Butcher JW; Carroll SS; DiMuzio J; Fandozzi C; Gilbert KF; Mao SS; McIntyre CJ; Nguyen KT; Romano JJ; Stahlhut M; Wan BL; Olsen DB; Vacca JP
    J Am Chem Soc; 2008 Apr; 130(14):4607-9. PubMed ID: 18338894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of macrocyclic thiodepsipeptides: synthesis of a nosiheptide 'southern hemisphere' model system.
    Kimber MC; Moody CJ
    Chem Commun (Camb); 2008 Feb; (5):591-3. PubMed ID: 18209799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors.
    Raboisson P; Lin TI; Kock Hd; Vendeville S; Vreken WV; McGowan D; Tahri A; Hu L; Lenz O; Delouvroy F; Surleraux D; Wigerinck P; Nilsson M; Rosenquist S; Samuelsson B; Simmen K
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5095-100. PubMed ID: 18722116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of placebo: is it a boon or bane?
    Girish C
    Gastroenterology; 2005 Mar; 128(3):805. PubMed ID: 15765430
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibitors of hepatitis C virus NS3/4A: alpha-ketoamide based macrocyclic inhibitors.
    Avolio S; Robertson K; Hernando JI; DiMuzio J; Summa V
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2295-8. PubMed ID: 19285390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The entropy balance of nostocyclopeptide macrocyclization analysed by NMR spectroscopy.
    Enck S; Kopp F; Marahiel MA; Geyer A
    Chembiochem; 2008 Nov; 9(16):2597-601. PubMed ID: 18821552
    [No Abstract]   [Full Text] [Related]  

  • 29. Total synthesis of the thiopeptide antibiotic amythiamicin D.
    Hughes RA; Thompson SP; Alcaraz L; Moody CJ
    J Am Chem Soc; 2005 Nov; 127(44):15644-51. PubMed ID: 16262432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total synthesis of the aspercyclides.
    Pospísil J; Müller C; Fürstner A
    Chemistry; 2009 Jun; 15(24):5956-68. PubMed ID: 19418521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of the HCV protease inhibitor Vaniprevir (MK-7009) using ring-closing metathesis strategy.
    Kong J; Chen CY; Balsells-Padros J; Cao Y; Dunn RF; Dolman SJ; Janey J; Li H; Zacuto MJ
    J Org Chem; 2012 Apr; 77(8):3820-8. PubMed ID: 22458448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C drug being developed.
    AIDS Patient Care STDS; 2004 Jan; 18(1):62. PubMed ID: 15080102
    [No Abstract]   [Full Text] [Related]  

  • 33. Gram-scale synthesis of iejimalide B.
    Gagnepain J; Moulin E; Fürstner A
    Chemistry; 2011 Jun; 17(25):6964-72. PubMed ID: 21557354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent triazolyl-proline-based inhibitors of HCV NS3 protease.
    Naud J; Lemke C; Goudreau N; Beaulieu E; White PD; Llinàs-Brunet M; Forgione P
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3400-4. PubMed ID: 18448339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects.
    Bartels DJ; Zhou Y; Zhang EZ; Marcial M; Byrn RA; Pfeiffer T; Tigges AM; Adiwijaya BS; Lin C; Kwong AD; Kieffer TL
    J Infect Dis; 2008 Sep; 198(6):800-7. PubMed ID: 18637752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereocontrolled synthesis of the quinaldic acid macrocyclic system of thiostrepton.
    Nicolaou KC; Safina BS; Funke C; Zak M; Zécri FJ
    Angew Chem Int Ed Engl; 2002 Jun; 41(11):1937-40. PubMed ID: 19750639
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis, characterisation and anti-protozoal activity of carbamate-derived polyazamacrocycles.
    Wilson JM; Giordani F; Farrugia LJ; Barrett MP; Robins DJ; Sutherland A
    Org Biomol Chem; 2007 Nov; 5(22):3651-6. PubMed ID: 17971994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of aromatic-aromatic interactions on the conformational stabilities of macrocycle and preorganized structure during macrocyclization.
    Katagiri K; Tohaya T; Masu H; Tominaga M; Azumaya I
    J Org Chem; 2009 Apr; 74(7):2804-10. PubMed ID: 19267486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease.
    Venkatraman S; Velazquez F; Wu W; Blackman M; Chen KX; Bogen S; Nair L; Tong X; Chase R; Hart A; Agrawal S; Pichardo J; Prongay A; Cheng KC; Girijavallabhan V; Piwinski J; Shih NY; Njoroge FG
    J Med Chem; 2009 Jan; 52(2):336-46. PubMed ID: 19102654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward the macrocidins: macrocyclization via Williamson etherification of a phenolate.
    Barnickel B; Schobert R
    J Org Chem; 2010 Oct; 75(19):6716-9. PubMed ID: 20828139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.